Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
'This means war'
Arrested, charged w/ fraud
2 shot at graduation event
Official images of B21 Raider
Gets Walk of Fame star
'Doge' meme dog dies
At least 100 killed in landslide
Judge revisits immigration law
US service members injured
Planet that could support life
First teaser revealed
Bong's plane discovered?
Support AIDS research
Ala. coal ash plan rejected
2022 Osprey crash lawsuit
Duggan can be extradited
Pistons new president?
Drops ‘Dark Times' album
Priest bites woman?
US issues visa restrictions
Lovett joins ‘Survivor’ cast
To hold output policy meeting
Approves ETFs for Ether
Final Astroworld suit settled
Daytime Emmy Awards hosts
CIA director to visit Europe
China's 2nd day of war games
Wins Idaho caucuses
Lucid to cut workforce by 6%
AI deals with Hollywood?
ISR Rafah offensive ruling
'My eyeball was out'
OH gov. calls special session
Bodies of 3 hostages found
Acapulco arm attack: 5 dead
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, FDA and RSV vaccine
FDA delays decision on Moderna's RSV shot until the end of May
The FDA needs a few more weeks to decide the fate of Moderna's RSV vaccine, the company announced. A decision is now slated for the end of May, as opposed to May 12.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Key Takeaways Moderna said the Food and Drug Administration (FDA) has delayed its approval decision for the respiratory syncytial virus (RSV) vaccine.The biotech reported it was advised by regulators that their review wouldn't be completed until the end of the month,
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
US regulators’
decision
on whether to approve Moderna Inc.’s
vaccine
for
RSV
has been delayed due to “administrative constraints” at the Food and
Drug
Administration, as the company works ...
Yahoo Finance
14d
FDA delays decision on Moderna RSV vaccine
Moderna on Friday said the Food and
Drug
Administration has postponed an approval
decision
on its experimental
vaccine
for
respiratory syncytial virus
due to “administrative constraints ...
13d
FDA delays decision date for Moderna's RSV vaccine
Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback